C2Dx Launches Next Generation Shaw Scalpel System – The Only Surgical Scalpel That Seals Vessels as it Cuts
Next Generation Shaw Scalpel Receives 510(k) Clearance, Ushering in a New Era of Surgical PrecisionKALAMAZOO, MI / ACCESSWIRE / March...
Month: March 2024
Merck Foundation Strengthens Its Commitment to Expanding Access to Care in Asia-Pacific Region
RAHWAY, NJ / ACCESSWIRE / March 26, 2024 / The Merck Foundation, a private charitable organization funded by Merck (NYSE:MRK),...
Winn Awards Help Physicians Solve Healthcare Disparities
NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Dr. Thomas Odeny grew up in rural Kenya during the height...
Medidata Wins Inaugural SCOPE Site Innovation Award for Pioneering Advancements in Site Experience with Leading-Edge Technology
Medidata Rave Companion, the industry’s first data entry companion, is recognized for improving the speed and accuracy of information capture...
TruBridge Announces Adoption of Limited Duration Stockholder Rights Plan
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) (the “Company”), a healthcare solutions company, announced today that its Board of Directors (the...
COPE Health Solutions Welcomes International Health Technology Expert Onto Its Board of Directors
Leading technology-enabled solutions firm helps health care providers and payers improve quality and financial performance through value-based careLOS ANGELES--(BUSINESS WIRE)--#analyticsforriskcontracting--COPE...
Unite Us Enables CBO Reimbursement Under Oregon’s 1115 Medicaid Waiver
Connect Oregon streamlines Medicaid billing for community-based organizations (CBOs) using Unite Us Payments, increasing access to vital social services for...
Leading Pioneer in Treatment of TMJ/TMD to Partner with In Hand Dental for Patient Monitoring
Dr. Anthony P. Urbanek, D.D.S., M.S., M.D., one of the country's most highly regarded Oral and Maxillofacial Surgeons and pioneer...
SphingoTec Announces Management Changes
BERLIN, GERMANY / ACCESSWIRE / March 26, 2024 / Diagnostic company SphingoTec announces a significant change in its management team....
Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System
Preliminary SI Joint Fusion Results Based on Independent Radiologist Review Indicate Robust Fusion at 12-Months Post-ProcedureInitial Patient Results Demonstrate Marked...
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
SAN DIEGO, CA / ACCESSWIRE / March 26, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a...
IntraBio Announces U.S. FDA Accepts New Drug Application for IB1001 for the Treatment of Niemann-Pick Disease Type C
IntraBio's IB1001 New Drug Application was accepted and granted priority reviewPDUFA date set for September 24th, 2024Application based on positive...
Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association
TORONTO, ON / ACCESSWIRE / March 26, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data
On track to achieve 250 patient enrollment target in March 2024Top-line data for 32-week primary endpoint expected in the first...
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
mRNA-1283 induced a more robust immune response compared to Spikevax® COVID-19 vaccine, mRNA-1273.222Next-generation mRNA vaccine design offers the potential of...
PharmAla Biotech Signs Sale Agreement with Numinus
LaNeo Product Data submitted for a Clinical Trial in CanadaTORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc....
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
- Company to host conference call and webcast featuring key opinion leaders on Monday, April 8, 2024 at 8:00 a.m....
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
The first trial using a C1 produced monoclonal antibody provides equivalent protection against SARS-CoV-2 in hamster and nonhuman primate models...
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
FREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical...
Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months
JERUSALEM, March 26, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the...